Filed with the SEC on · Summarized by InvestorsBot
Jennifer L. Taubert, Johnson & Johnson’s EVP, Worldwide Commercialization, Innovative Medicine, sold 15,000 common shares on Aug. 17 at $263.36 per share, for approximately $3,950,400. She owned 194,451.001 shares after the sale.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeJohnson & Johnson reports 5.9% sales growth and raises 2026 guidance
8-K · October 13, 2026
JNJ EVP Timothy Schmid sells $9.2M in stock
Form 4 · Insider Trade · September 4, 2026
J&J CEO Joaquin Duato sells approximately $32.2M in stock
Form 4 · Insider Trade · August 14, 2026
J&J CEO Joaquin Duato sells approximately $12.5M in stock
Form 4 · Insider Trade · August 7, 2026
J&J Chief Legal Officer sells $4.1M in stock
Form 4 · Insider Trade · August 7, 2026
J&J names Tom Cavanaugh to lead Innovative Medicine as Jennifer Taubert retires
8-K · August 4, 2026